Citations

Clear

6728 citation(s) found for "Su, Mark K".

HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply
Jochumsen, Emilie A , Seheult, Jansen N , Sprogøe, Ulrik , Vieni, Casey , Yazer, Mark H

Mayo Clinic

Transfusion | November 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/trf.70485 | PMID 43031507 Get It

Abstract Background Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA‐antibody screening was implemented in different strategies. Methods Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA‐antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA‐antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD‐negative and RhD‐positive donors. Results The model calculated that there would be 222,239 RhD‐negative male and 74,655 nulliparous RhD‐negative female donors. If all group O RhD‐negative parous females were screened, 109,479 were calculated to not be HLA‐sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD‐negative females ≥50 years were screened, 59,138 donors would not be HLA‐sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD‐negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA‐sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD‐positive males and females were modeled. Conclusion HLA‐antibody screening realizes additional LTOWB donors.
IMPACT OF ORGANISM PROFILE ON IDEAL TIMING OF REIMPLANTATION IN PATIENTS UNDERGOING TWO-STAGE EXCHANGE ARTHROPLASTY
Tarabichi, Saad , Moore, Lane, Braithwaite, Collin , Verhey, Jens, Springer, Bryan, Wyles, Cody C. , Spangehl, Mark J. , Bingham, Joshua S.

Mayo Clinic

Orthopaedic Proceedings | November 6, 2026 | Volume: 108-B | Issue: SUPP_11 | Pages: 28-28

10.1302/1358-992x.2026.11.028 Get It

Introduction No study to date has examined the association between organism profile and ideal interstage duration in patients undergoing two-stage exchange arthroplasty. The purpose of this study was to evaluate the impact of the type of infecting organism on the optimal timing of reimplantation in this patient population. Methods This retrospective study identified 576 patients with chronic periprosthetic joint infection (PJI) of the knee that underwent two-stage exchange arthroplasty with a minimum 1-year follow-up. PJI was defined using the 2013 Musculoskeletal Infection Society (MSIS) criteria. Patients with a time to reimplantation >180 days from resection arthroplasty (n=76) and those that underwent spacer exchange were excluded (n=49). Treatment failure was defined as any reoperation for infection or PJI-related mortality. Receiver operator characteristic (ROC) curve analyses were used to identify whether the optimal interstage duration differed by infecting organism. Multivariate regression analyses were performed to identify risk factors for failure. Results 451 patients with a mean follow-up time of 5.8 ± 3.6 years were included. Of these, 71 (15.7%) patients experienced failure and 380 (84.3%) experienced success. ROC curve analyses demonstrated that the optimal interstage duration was longest for patients infected with “high-virulence” pathogens (129 days), followed by those with MSSA (117 days), culture negative PJI (98 days), and coagulase-negative Staphylococci (86 days). After controlling for co-variates, regression analyses showed that an interstage duration above the identified cutoff for each pathogen group was a predictor of treatment failure (all p<0.05). Conclusion We found that the ideal interstage duration varied considerably by the type of infecting organism in patients undergoing two-stage exchange. Greater awareness of this data may help guide the optimal timing of reimplantation in this patient population.
ALPHA-DEFENSIN HAS POOR UTILITY IN THE DIAGNOSIS OF ACUTE POSTOPERATIVE PJI: A MULTICENTRE STUDY
Tarabichi, Saad , Verhey, Jens, Braithwaite, Collin , Moore, Lane, Hofstaetter, Jochen , Sebastian, Sujeesh , Çıtak, Mustafa , Spangehl, Mark J. , Bingham, Joshua

Mayo Clinic

Orthopaedic Proceedings | November 6, 2026 | Volume: 108-B | Issue: SUPP_11 | Pages: 90-90

10.1302/1358-992x.2026.11.090 Get It

Introduction The alpha-defensin test has witnessed a surge in popularity following reports of its superior diagnostic capabilities, when compared to more conventional synovial markers. Despite this, no study to date has evaluated the utility of alpha-defensin for the diagnosis of acute periprosthetic joint infection (PJI). The purpose of this multicenter study was to determine whether the alpha-defensin test provided additional clinical benefit, when compared to synovial white blood cell (WBC) count and polymorphonuclear leukocyte percentage (PMN%), in the diagnosis of acute postoperative PJI. Methods This retrospective study identified all patients who underwent arthrocentesis within 90 days of their primary total joint arthroplasty (TJA) at three institutions. PJI was defined as revision TJA for infection within 2-weeks of joint aspiration with >=1 positive intraoperative culture. Patients were considered aseptic if they had no reoperation for >=1-year after arthrocentesis. Receiver operator characteristic (ROC) curves were used to assess the utility of alpha-defensin, WBC count, and PMN% in the diagnosis of acute PJI. Pairwise comparison was performed to compare whether the area under the curve (AUC) was significantly different between the three markers. Results A total of 143 patients were included. Of these, 85 (59.4%) were infected and 58 (40.6%) were aseptic. After plotting ROC curves, WBC count was found to have the highest diagnostic utility (AUC 0.912, sensitivity 80.0%, specificity 91.2%), followed by PMN% (AUC 0.869, sensitivity 70.5%, specificity 93.0%), and alpha-defensin (AUC 0.812, sensitivity 62.4%, specificity 100%). Using pairwise comparison, the AUC for WBC count was found to be significantly higher than that of alpha-defensin (p=0.005). However, there was no difference in the AUC between alpha defensin and PMN% (p=0.154). Conclusion Based on our findings, it appears that alpha-defensin provides little to no additional clinical benefit in the diagnosis of acute PJI, when compared to synovial WBC count and PMN%.
Renal Cortical Siderosis: Imaging Findings and Clinical Relevance
Shah, Amar S , Chen, Kyle J , Sugi, Mark D

Mayo Clinic

BJR|Case Reports | October 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/bjrcr/uaag043 | PMID 42927408 Get It

Abstract Renal cortical hemosiderosis is the accumulation of iron in the renal cortex. On MRI, this can be inferred by marked cortical T2 hypointensity and loss of signal on in-phase imaging relative to opposed-phase imaging. Although classically associated with paroxysmal nocturnal hemoglobinuria, renal hemosiderosis can be seen in a variety of pathologic conditions associated with acute or chronic renal injury. We present a case of a 59-year-old female that developed acute kidney injury while hospitalized for management of hydronephrosis and hepatic abscess with imaging features on MR angiography and renal parenchymal biopsy consistent with renal cortical hemosiderosis. Combined with other laboratory results, this finding expedited the diagnosis of atypical hemolytic uremic syndrome, a condition with poor prognosis for which timely treatment is essential. Thus, recognition of renal cortical hemosiderosis on imaging may facilitate appropriate clinical workup and timely management.
Cost comparison of the ShangRing device versus Mogen clamp for early infant male circumcision in Sub-Saharan Africa
Punjani, Nahid, Zhang, Tenny R. , Basourakos, Spyridon P. , Barone, Mark A. , Christensen, Alice , Kigozi, Godfrey, Goldstein, Marc, Li, Philip S. , Mushlin, Alvin I. , Stover, John , Lee, Richard K.

Mayo Clinic

PLOS One | October 13, 2026 | Volume: 21 | Issue: 10 | Pages: e0360356

10.1371/journal.pone.0360356 | PMID 42868147 Get It

Introduction The World Health Organization (WHO) endorses male circumcision as an effective human immunodeficiency virus (HIV) prevention intervention in settings where the expected impact is greatest, including Sub-Saharan Africa. Data on cost implications of early infant male circumcision (EIMC) are limited. The ShangRing (SR) is a WHO pre-qualified device for circumcision. We sought to perform a comprehensive cost assessment alongside a randomized controlled trial (RCT) of the SR versus the standard of care Mogen clamp (MoC) for EIMC to enable future scale-up towards a cost-effective HIV prevention strategy. Methods We collected resource utilization and economic data as part of an RCT of infants aged 0–60 days old undergoing EIMC in Kenya, Tanzania, and Uganda. Cost data for both the SR and MoC included baseline facility costs, direct costs, and indirect costs. The Decision Makers Program Planning Tool v1.0 was used to perform a direct cost comparison of these two devices. The Goals model was used to compare the costs of EIMC in 2023 using the present value of money to circumcise an adolescent male 15 years from now. Results A total of 1,378 infant males underwent circumcision, 689 via SR and 689 via MoC. The overall cost of a single EIMC in Kenya, Tanzania, and Uganda were 61.30 United States Dollars ($), $47.14, and $64.59 respectively for the SR, and $56.38, $50.43, and $58.57 respectively for the MoC. In Kenya, EIMC would be less expensive based on nominal present costs in 2023 compared to waiting for adolescent circumcision at age 15 years in 2038. This finding is reversed in Tanzania and Uganda. Conclusions The overall cost of EIMC via SR versus MoC is comparable in an RCT. With scale-up utilizing lower level personnel, the cost of SR may be further reduced. The SR is an attractive alternative for future EIMC initiatives in Sub-Saharan Africa to further reduce HIV burden.
Estimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective
Doré, Michaël , Ebner, Derek W. , Fendrick, A. Mark , Estes, Chris , Aranda, Gustavus, Coleman, Amber, Vahdat, Vahab , Karlitz, Jordan J. , Rua, Tiago , van Hees, Frank , Limburg, Paul J.

Mayo Clinic

Journal of Medical Economics | October 1, 2026 | Volume: 29 | Issue: 1 | Pages: 2228-2240

10.1080/13696998.2026.2719374 | PMID 42821825 Get It

BCL-2 for ALL
Litzow, Mark R.

Mayo Clinic

Blood | September 24, 2026 | Volume: 148 | Issue: 13 | Pages: 1642-1644

10.1182/blood.2026034920 | PMID 42783359 Get It

Single-cell immune repertoire atlas maps coordinated circulating adaptive immune states in inflammatory bowel disease
Gubatan, John , Ye, Jiayu, Lund‐Andersen, Christin , Canas, Jorge, Zhou, Yuxi , Boye, Theresa, Hoang, Jacqueline, Sojwal, Raoul, Fardeen, Touran , Tran, Tracy, Sokzini, Peacha, Koh, Ally H, Gibson, Marielle, Huang, Yuting , Peterson, Kathryn , Sinha, Sidhartha, Rogalla, S, Nielsen, Ole Haagen , Rosen, Michael J, Zhou, Yuxi , Canas, Jorge , Huang, Yuting , Ye, Jiayu, Boye, Theresa Louise , Hoang, Jacqueline, Sojwal, Raoul S. , Tracy, Tran, Rosen, Michael J., Sandve, G K , Gubatan, John Mark , Sinha, Sidhartha R.

Mayo Clinic

No container title available | September 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.20.753043 | PMID 42817982 Get It

Single-cell studies have defined immune states in inflammatory bowel disease (IBD), but how adaptive receptor histories organize circulating immunity remains unclear. We generated a single-cell transcriptomic atlas of peripheral blood from 249 participants with Crohn's disease, ulcerative colitis, or non-IBD control status, including 182 with productive TCR and BCR recovery. Expanded TCR clonotypes marked inflammatory-memory and cytotoxic states, while distinct but similar paired TCRs shared inflammatory programs across participants. BCR lineage maturation linked IgA-associated mucosal and plasma B cell programs to somatic mutation and class switching, distinguishing maturation-associated biology from clonal expansion. Helper, regulatory, and cytotoxic T-cell programs covaried with B-cell states, and inferred interactions nominated reciprocal antigen-presentation and helper pathways. Repertoire-based machine learning distinguished diagnosis, inflammation, and contemporaneous six-month treatment-response status. Together, this atlas connects receptor architecture to coordinated systemic immune remodeling, establishes a foundation for repertoire-informed patient stratification, and prioritizes candidate mechanisms of IBD pathogenesis.
Single-cell profiling reveals stromal niche and α5β1 regulation of neutrophil phenotypes in ulcerative colitis
Zhou, Yuxi , Canas, Jorge , Ye, Jiayu , Hoang, Jacqueline, Ferkel-Soltau, Sonia, Holman, Derek, Sojwal, Raoul, Fardeen, Touran , Vazques, Gustavo, Huang, Yuting , Peterson, Kathryn , Nolan, Garry, Sinha, Sidhartha, Rogalla, S, Gubatan, John , Huang, Yuting , Hoang, Jacqueline, Sojwal, Raoul S. , Nolan, Garry P. , Gubatan, John Mark

Mayo Clinic

No container title available | September 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.21.753318 | PMID 42818174 Get It

Abstract Background and Aims Fibroblast–neutrophil interactions are implicated in ulcerative colitis (UC) treatment resistance, but whether fibroblasts modify neutrophil inflammatory activity remains unclear. We investigated responses to fibroblast exposure, stromal depletion, and α5β1-directed treatment. Methods We integrated human and mouse colonic single-cell RNA sequencing (scRNA-seq), spatial protein profiling (CODEX), fibroblast–neutrophil coculture, and dextran sulfate sodium (DSS) mouse colitis with fibroblast activation protein (FAP) ablation or α5β1-directed treatment. Readouts included cellular representation and protein fluorescence via flow cytometry, neutrophil extracellular trap (NET)-associated elastase activity, RNA programs and epithelial responses using scRNA-seq. Results Inflamed UC tissue contained higher fractions of inflammatory fibroblasts and oncostatin M (OSM)- and CXCR4-associated neutrophils. Inflammatory fibroblasts had higher FAP–α5β1 module scores, and proximity to FAP-high fibroblasts was associated with higher neutrophil OSM and CXCR4 fluorescence. UC fibroblasts increased neutrophil OSM, CXCR4 and myeloperoxidase (MPO) fluorescence and NET-associated elastase activity relative to control fibroblasts, while α5β1-directed treatment attenuated these responses. Both mouse FAP ablation and α5β1 blockade in DSS colitis reduced histologic inflammation and overall neutrophil frequency. Ablation broadly reduced recovered neutrophil representation, whereas blockade increased OSM-positive and PADI4-positive percentages within neutrophils despite lower MPO fluorescence within these subsets. Both interventions were associated with lower epithelial chemokine scores but distinct absorptive and mucus/secretory responses. Conclusions Fibroblast exposure modifies neutrophil inflammatory phenotype and effector-associated activity, identifying candidate therapeutic pathways in UC. Evaluating these responses alongside neutrophil representation and tissue inflammation could inform pharmacodynamic assessment of stromal-directed therapies. Graphical Abstract What You Need to Know Background and Context Fibroblast–neutrophil interactions are associated with treatment resistance in ulcerative colitis. Whether fibroblast exposure modifies neutrophil inflammatory phenotype and effector activity, beyond its established recruitment role, remains unclear. New Findings UC fibroblasts increased neutrophil inflammatory proteins and NET-associated elastase activity; α5β1-directed treatment attenuated these responses. FAP ablation and α5β1-directed treatment reduced colitis and overall neutrophil frequency. α5β1-directed treatment lowered MPO within OSM-positive and PADI4-positive neutrophils despite higher marker-positive percentages. Epithelial single-cell RNA sequencing revealed reduced chemokine programs with both interventions but distinct barrier-associated and regenerative expression patterns. Limitations Cellular drug targets remain unresolved. Spatial associations and elastase activity do not establish direct contact, NET formation, or clinical efficacy. Clinical Research Relevance Fibroblast-associated pathways offer candidate therapeutic opportunities to modify neutrophil inflammatory phenotype and effector activity in UC. Coculture responses were pharmacologically modifiable, and stromal interventions reduced experimental colitis. Measuring neutrophil frequency, subset proteins, and effector activity alongside tissue inflammation could guide pharmacodynamic assessment. Clinical efficacy and treatment-selection utility require validation. Basic Research Relevance Human coculture provides experimental evidence that fibroblast exposure modifies neutrophil inflammatory proteins and NET-associated elastase activity. FAP+ stromal ablation and α5β1-directed treatment produced distinct patterns of neutrophil representation and subset proteins in colitis. Epithelial single-cell RNA sequencing revealed reduced chemokine programs with both interventions but differing barrier-associated and regenerative expression patterns. Together, these findings motivate mechanistic studies of how stromal recruitment cues, soluble signals, and matrix-associated interactions regulate neutrophil responses, and whether these changes contribute to reduced epithelial inflammation and tissue repair. Lay Summary Fibroblasts, support cells in the intestine, increased inflammatory activity in immune cells called neutrophils. Blocking a pathway involved in cell attachment reduced these responses in cultures. Targeting fibroblast-associated pathways also reduced experimental colitis, with changes in intestinal lining gene activity related to inflammation, barrier function, and repair. These findings suggest potential approaches to treating ulcerative colitis.